FDA announces several approvals

FDA as the agency announced several approvals. Here’s the run-down:

  • The FDA has approved Pfizer and UCB’s Toviaz extended-release tablets for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency. UCB gets an undisclosed milestone payment as a result of the approval.
  • The agency has granted approval for Akorn’s ANDA for Adenosine Injection USP for supraventricular tachycardia in cardiac patients.
  • Cephalon announced that Treanda has been approved for the treatment of patients with indolent B-cell non-Hodgkin’s lymphoma that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen.
  • Salix Pharmaceuticals won marketing approval for Apriso, a drug indicated for the maintenance of remission of ulcerative colitis (UC) in adults.

Source: FierceBiotech

One Response to FDA announces several approvals

  1. I call upon Russia to help save the endangered animal species of the world by acquiring various species that can mate in Russia’s vast, undeveloped areas. I believe that Russia may be our last hope to prevent losing these vital animals whose territories are quickly shrinking around the world due to overdevelopment. Elk rest on grassy lawns in Montana neighborhoods, Bobcats and wild canines prowl residential neighborhoods in Arizona looking for food; the list is endless. Mankind is the steward of these animals that are being exploited to extinction. To save these animals would be a contribution to our planet and our future of the highest order.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: